Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial
Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorde...
Saved in:
Published in | Journal of clinical psychopharmacology Vol. 41; no. 5; p. 540 |
---|---|
Main Authors | , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
United States
01.09.2021
|
Subjects | |
Online Access | Get more information |
ISSN | 1533-712X |
DOI | 10.1097/JCP.0000000000001428 |
Cover
Abstract | Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorder.
Seventeen volunteers with social anxiety disorder participated in a pilot, proof-of-concept, randomized, parallel-group trial. Self-perception of performance during a public-speaking test was assessed with the Self-statements During Public Speaking Scale primary outcome). Secondary outcomes included anxiety/subjective effects (Visual Analog Mood Scale; Bodily Symptoms Scale), recognition of emotions in facial expressions (REFE), tolerability measures (cardiovascular measures, self-reports), and brain-derived neurotrophic factor plasma levels. Effects on anxiety and REFE were assessed again 7, 14, and 21 days postdrug.
Compared with placebo, ayahuasca significantly improved self-perception of speech performance (Self-statements During Public Speaking Scale) and increased somatic symptoms (Bodily Symptoms Scale). There was also a significant time × group interaction in the cognitive deterioration Visual Analog Mood Scale factor and a significant effect of time in the REFE task, especially in reaction time. Other measures were not significantly modified. Ayahuasca was well tolerated, producing mainly nausea, gastrointestinal discomfort, and vomiting.
Ayahuasca improved self-perception of speech performance in socially anxious individuals. These effects occurred independent of task-related anxiety and REFE, suggesting that ayahuasca could specifically improve the cognitive aspect of speech performance. Further studies should try to unveil the mechanisms involved in the effects of ayahuasca and to better understand its effects on anxiety. |
---|---|
AbstractList | Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing, speech). This controlled trial assessed the effects of ayahuasca on speech performance and anxiety in individuals with social anxiety disorder.
Seventeen volunteers with social anxiety disorder participated in a pilot, proof-of-concept, randomized, parallel-group trial. Self-perception of performance during a public-speaking test was assessed with the Self-statements During Public Speaking Scale primary outcome). Secondary outcomes included anxiety/subjective effects (Visual Analog Mood Scale; Bodily Symptoms Scale), recognition of emotions in facial expressions (REFE), tolerability measures (cardiovascular measures, self-reports), and brain-derived neurotrophic factor plasma levels. Effects on anxiety and REFE were assessed again 7, 14, and 21 days postdrug.
Compared with placebo, ayahuasca significantly improved self-perception of speech performance (Self-statements During Public Speaking Scale) and increased somatic symptoms (Bodily Symptoms Scale). There was also a significant time × group interaction in the cognitive deterioration Visual Analog Mood Scale factor and a significant effect of time in the REFE task, especially in reaction time. Other measures were not significantly modified. Ayahuasca was well tolerated, producing mainly nausea, gastrointestinal discomfort, and vomiting.
Ayahuasca improved self-perception of speech performance in socially anxious individuals. These effects occurred independent of task-related anxiety and REFE, suggesting that ayahuasca could specifically improve the cognitive aspect of speech performance. Further studies should try to unveil the mechanisms involved in the effects of ayahuasca and to better understand its effects on anxiety. |
Author | Osório, Flávia de Lima Dos Santos, Rafael G Rodrigues, Lucas S de Oliveira Silveira, Gabriela Rossi, Giordano Novak Bouso, José Carlos Hallak, Jaime E Cecílio Rocha, Juliana Mendes Yonamine, Mauricio |
Author_xml | – sequence: 1 givenname: Rafael G surname: Dos Santos fullname: Dos Santos, Rafael G – sequence: 2 givenname: Flávia de Lima surname: Osório fullname: Osório, Flávia de Lima – sequence: 3 givenname: Juliana Mendes surname: Rocha fullname: Rocha, Juliana Mendes organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto – sequence: 4 givenname: Giordano Novak surname: Rossi fullname: Rossi, Giordano Novak organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto – sequence: 5 givenname: José Carlos surname: Bouso fullname: Bouso, José Carlos – sequence: 6 givenname: Lucas S surname: Rodrigues fullname: Rodrigues, Lucas S organization: From the Department of Neurosciences and Behavior, Ribeirão Preto Medical School, University of São Paulo, Ribeirão Preto – sequence: 7 givenname: Gabriela surname: de Oliveira Silveira fullname: de Oliveira Silveira, Gabriela organization: School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil – sequence: 8 givenname: Mauricio surname: Yonamine fullname: Yonamine, Mauricio organization: School of Pharmaceutical Sciences, University of Sao Paulo, São Paulo, Brazil – sequence: 9 givenname: Jaime E Cecílio surname: Hallak fullname: Hallak, Jaime E Cecílio |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/34166299$$D View this record in MEDLINE/PubMed |
BookMark | eNpNkOtKwzAcxYMo7qJvIJIHWGeT9Ba_lXqbDCx2ot9GmvzDMtqmpJ04H8cntUMFDwcOnAO_D2eCjhvbAEIXxJ8Tn8dXj1k-9_-JBDQ5QmMSMubFhL6N0KTrtoc-puEpGrGARBHlfIy-0r3Y7EQnBV7UrbPv0OECKu214CS0vbENthoXLYDc4Byctq4WjQRsGlzsyi3IvsOvpt_gwkojKpw2Hwb6Pb4xnXUK3DVOcW4q289w7qzV3uDMNgf4DD-LRtnafIIa1kpIKO1h7J2tKlB45QbiGTrRourg_Den6OXudpU9eMun-0WWLj3JQhp5nNGEsZiWSgY84TIM4gR0RBWJOQ15qSkMfKJpCZGv_ECGOogUZZz5ImTDHVN0-cNtd2UNat06Uwu3X_-dRb8BNQ1uOA |
CitedBy_id | crossref_primary_10_1016_j_ijchp_2022_100349 crossref_primary_10_3389_fpsyt_2024_1431389 crossref_primary_10_1016_j_psychres_2024_115880 crossref_primary_10_1177_02698811221116926 crossref_primary_10_3390_biom12111618 crossref_primary_10_1007_s41603_023_00203_y crossref_primary_10_1016_j_jep_2023_117430 crossref_primary_10_3390_molecules27082520 crossref_primary_10_1016_j_psychres_2024_115886 crossref_primary_10_1080_02791072_2024_2424288 crossref_primary_10_1080_14740338_2022_2054988 crossref_primary_10_1016_j_pnpbp_2023_110738 crossref_primary_10_1093_schbul_sbad094 crossref_primary_10_1097_JCP_0000000000001941 crossref_primary_10_1097_JCP_0000000000001888 crossref_primary_10_1016_j_neubiorev_2024_105570 crossref_primary_10_1080_14740338_2022_2063274 crossref_primary_10_1016_j_neuropharm_2025_110413 crossref_primary_10_1038_s41380_024_02800_5 crossref_primary_10_61373_pp024i_0037 crossref_primary_10_1080_02791072_2022_2077155 crossref_primary_10_2174_1570159X20666220425133824 crossref_primary_10_3389_fpsyt_2024_1485337 crossref_primary_10_1016_j_pnpbp_2025_111279 crossref_primary_10_7759_cureus_55574 crossref_primary_10_1007_s40263_024_01101_3 crossref_primary_10_1177_02698811241273772 crossref_primary_10_1017_S109285292400213X crossref_primary_10_1080_14737175_2024_2445016 crossref_primary_10_1177_20451253231172254 crossref_primary_10_1089_psymed_2023_0007 crossref_primary_10_1111_nyas_15082 crossref_primary_10_1002_pcn5_146 crossref_primary_10_1016_j_jpsychires_2025_03_022 crossref_primary_10_1089_psymed_2023_0028 crossref_primary_10_1177_02698811231155117 crossref_primary_10_1097_JCP_0000000000001536 crossref_primary_10_1097_JCP_0000000000001872 crossref_primary_10_1016_j_euroneuro_2022_10_008 crossref_primary_10_1007_s00213_024_06598_6 crossref_primary_10_1097_JCP_0000000000001691 |
ContentType | Journal Article |
Copyright | Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
Copyright_xml | – notice: Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
DBID | CGR CUY CVF ECM EIF NPM |
DOI | 10.1097/JCP.0000000000001428 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | no_fulltext_linktorsrc |
Discipline | Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1533-712X |
ExternalDocumentID | 34166299 |
Genre | Randomized Controlled Trial Journal Article |
GroupedDBID | --- .-D .3C .GJ .Z2 01R 0R~ 1CY 1J1 3O- 40H 4Q1 4Q2 4Q3 53G 5GY 5RE 5VS 71W 77Y 7O~ 8L- AAAAV AAAXR AAGIX AAHPQ AAIQE AAMOA AAMTA AAQKA AAQQT AARTV AASCR AASOK AAXQO AAYEP ABASU ABBUW ABDIG ABIVO ABJNI ABVCZ ABXVJ ABZAD ABZZY ACCJW ACDDN ACEWG ACGFO ACGFS ACIJW ACILI ACLDA ACWDW ACWRI ACXJB ACXNZ ACZKN ADFPA ADGGA ADHPY ADNKB AE3 AE6 AEETU AENEX AFBFQ AFDTB AFFNX AFUWQ AGINI AHOMT AHQNM AHRYX AHVBC AIJEX AINUH AJCLO AJIOK AJNWD AJNYG AJZMW AKCTQ AKULP ALKUP ALMA_UNASSIGNED_HOLDINGS ALMTX AMJPA AMKUR AMNEI AOHHW AOQMC BOYCO BQLVK BS7 BYPQX C45 CGR CS3 CUY CVF DIWNM DU5 DUNZO E.X EBS ECM EEVPB EIF EJD ERAAH EX3 F2K F2L F2M F2N F5P FCALG FL- FW0 GNXGY GQDEL H0~ HLJTE HZ~ H~9 IKREB IKYAY IN~ JF9 JG8 JK3 JK8 K8S KD2 KMI L-C N4W N9A NEJ NPM N~7 N~B N~M O9- OAG OAH OCUKA ODA OL1 OLG OLH OLU OLV OLY OLZ OMH OPC OPUJH OPX ORVUJ OUVQU OVD OVDNE OVIDH OVLEI OWU OWV OWW OWX OWY OWZ OXXIT P-K P2P R58 RLZ S4R S4S T8P TEORI TSPGW V2I VVN W3M WOQ WOW X3V X3W XXN XYM YFH YOC ZFV ZGI ZXP ZY1 ZZMQN |
ID | FETCH-LOGICAL-c3526-93283372bdc4989c5478ef62d179259bf2eace1f2be60d04c5f46d23930a53662 |
IngestDate | Thu Apr 03 06:49:09 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 5 |
Language | English |
License | Copyright © 2021 Wolters Kluwer Health, Inc. All rights reserved. |
LinkModel | OpenURL |
MergedId | FETCHMERGED-LOGICAL-c3526-93283372bdc4989c5478ef62d179259bf2eace1f2be60d04c5f46d23930a53662 |
PMID | 34166299 |
ParticipantIDs | pubmed_primary_34166299 |
PublicationCentury | 2000 |
PublicationDate | 2021-09-01 |
PublicationDateYYYYMMDD | 2021-09-01 |
PublicationDate_xml | – month: 09 year: 2021 text: 2021-09-01 day: 01 |
PublicationDecade | 2020 |
PublicationPlace | United States |
PublicationPlace_xml | – name: United States |
PublicationTitle | Journal of clinical psychopharmacology |
PublicationTitleAlternate | J Clin Psychopharmacol |
PublicationYear | 2021 |
SSID | ssj0014725 |
Score | 2.5187478 |
Snippet | Ayahuasca is a classic hallucinogen with anxiolytic and antidepressive properties. Anecdotal evidence also suggests that it improves performance (eg, singing,... |
SourceID | pubmed |
SourceType | Index Database |
StartPage | 540 |
SubjectTerms | Adult Anti-Anxiety Agents - adverse effects Anti-Anxiety Agents - therapeutic use Banisteriopsis - adverse effects Female Humans Male Phobia, Social - drug therapy Pilot Projects Self Concept Speech Young Adult |
Title | Ayahuasca Improves Self-perception of Speech Performance in Subjects With Social Anxiety Disorder: A Pilot, Proof-of-Concept, Randomized, Placebo-Controlled Trial |
URI | https://www.ncbi.nlm.nih.gov/pubmed/34166299 |
Volume | 41 |
hasFullText | |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1Lb9NAEF41IFAviGd5aw6ol8Tg2OsXtxAoVQ_BqlLRW7W2d1WDa1ukrWh_Dr-UmV2_lLYIiCIr8lpWvPN5d2b2-2YZe5MoLxIZvt8i9LjFA8ezEof7FufKTlMnFIlhWyz83QO-d-gdbozuDFhLZ6fJ2_TyWl3J_1gVz6FdSSX7D5btboon8DfaF49oYTz-lY1nF-L4TKxSMTa5AbnCd79QVt2xVbQmpZYyPSaueycRyEsaMb5pJsdXysQ2Kt1Z-VNzONuanEa3HudFZci86GYrC79zI3bU9hFlVp3klyZpGlNWPqnoAmLAF-jOLqkjbvCBO12mEYPVfR3tLtP_scKHop2OTUpIKCGLfkOwLyta6f_g_sh1ynen0Av_0_NcjDNJ6q1u1tmvUrO2RYpwUQri82Y9gXIfnQVNbPic45OLshovqnPxfZgUcaYd6wvntHYgd61gqrdq70Z6U2KrQbQ3GLY9UzLqynRiyhTvzWNT5rL5UJG64eVoi_pEQwxdAt93zI5Pf25dK_LdNo3YKAhofllQ0qlZDKM3qFV9RsG76_7OJrvb3mItPtJ-0vI-u9cYF2YGrQ_Yhiwfsu3YWPZiAste8LeawDbEA5s_Yr86SEMLaViDNFQKDKRhAGnIS2ghDQRpMJCGBtLQQvo9zEADegLrcJ5AD2ZsvQJl0FB-zA52Pi3nu1azjYiV0uYPFkYooesGTpKlPAqjlCrYSeU7Gc5FGPwnykHnQ06Vk0jfzmyeeor7GZUGtIXnYp8-YbfKqpRPGfhOmGE8zjOOYbgtMDpSAuMTgUGIH3lh9Ixtmb4_qk2tmKPWKs9vbHnBNnsEv2S3FQ5O8hV6uqfJa42D33ChqHo |
linkProvider | National Library of Medicine |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Ayahuasca+Improves+Self-perception+of+Speech+Performance+in+Subjects+With+Social+Anxiety+Disorder%3A+A+Pilot%2C+Proof-of-Concept%2C+Randomized%2C+Placebo-Controlled+Trial&rft.jtitle=Journal+of+clinical+psychopharmacology&rft.au=Dos+Santos%2C+Rafael+G&rft.au=Os%C3%B3rio%2C+Fl%C3%A1via+de+Lima&rft.au=Rocha%2C+Juliana+Mendes&rft.au=Rossi%2C+Giordano+Novak&rft.date=2021-09-01&rft.eissn=1533-712X&rft.volume=41&rft.issue=5&rft.spage=540&rft_id=info:doi/10.1097%2FJCP.0000000000001428&rft_id=info%3Apmid%2F34166299&rft_id=info%3Apmid%2F34166299&rft.externalDocID=34166299 |